Geographical differences in the prevalence of chronic polypharmacy in older people: Eleven years of the EPIFARM-Elderly Project

European Journal of Clinical Pharmacology

Volumn 69, Issue 7, 2013, Pages 1477-1483

  Franchi, Carlotta ^a   Cartabia, Massimo ^a   Risso, Paolo ^a   Mari, Daniela ^b   Tettamanti, Mauro ^a   Parabiaghi, Alberto ^a   Pasina, Luca ^a   Djignefa Djade, Codjo ^a   Fortino, Ida ^c   Bortolotti, Angela ^c   Merlino, Luca ^c   Nobili, Alessandro ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Regional Health Ministry   (Italy)

Author keywords

Chronic polypharmacy; Clusters; Geographical difference; Older people

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL PRACTICE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POLYPHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TREND STUDY;

AGED; AGED, 80 AND OVER; AGING; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; ITALY; MALE; MORTALITY; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PRESCRIPTION DRUGS; SPATIO-TEMPORAL ANALYSIS; STATE MEDICINE;

EID: 84879088736     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1495-7     Document Type: Article

References (31)

1. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300:2867-2878
2. Hovstadius B, Petersson G (2012) Factors leading to excessive polypharmacy. Clin Geriatr Med 28:159-172
3. Veehof L, Stewart R, Haaijer-Ruskamp F et al (2000) The development of polypharmacy. A longitudinal study. Fam Pract 17:261-267
4. Bjerrum L, Rosholm JU, Hallas J et al (1997) Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 53:7-11
5. Jyrkka J, Enlund H, Lavikainen P et al (2011) Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 20:514-522
6. Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J (2009) The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc 57:62-69
7. Johnell K, Fastbom J, Rosen M, Leimanis A (2007) Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother 41:1243-1248
8. Johnell K, Klarin I (2007) The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 30:911-918
9. Fincke BG, Snyder K, Cantillon C, Gaehde S, Standring P, Fiore L, Brophy M, Gagnon DR (2005) Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 14:121-128
10. Hallas J (2005) Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol Drug Saf 14:455-463
11. Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius A, de Boer A (2001) Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 54:1181-1186
12. Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63:187-195
13. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG (2012) Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 65(9):989-995
14. Shah BM, Hajjar ER (2012) Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med 28:173-186
15. Tamura BK, Bell CL, Inaba M, Masaki KH (2012) Outcomes of polypharmacy in nursing home residents. Clin Geriatr Med 28:217-236
16. Patterson SM, Hughes CM, Kerse N, Cardwell C, Bradley M (2012) Interventions to improve appropriate polypharmacy for older people. (Review). Cochrane Database Syst Rev (5)
17. Aronson JK (2004) In defence of polypharmacy. Br J Clin Pharmacol 57(2):119-120
18. Barry PJ, Gallagher P, Ryan C, O'Mahony D (2007) START (Screening tool to alert doctors to the right treatment) - an evidence based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36:632-638
19. Nobili A, Franchi C, Pasina L, Tettamanti M, Baviera M, Monesi L, Roncaglioni C, Riva E, Lucca U, Bortolotti A, Fortino I, Merlino L (2011) Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-Elderly Project. Pharmacoepidemiol Drug Saf 20:488-496
20. Hovstadius B, Astrand B, Petersson G (2010) Assessment of regional variation in polypharmacy. Pharmacoepidemiol Drug Saf 19:375-383
21. Franchi C, Sequi M, Bonati M, Nobili A, Pasina L, Bortolotti A, Fortino I, Merlino L, Clavenna A (2011) Differences in outpatient antibiotic prescription in Italy's Lombardy region. Infection 39:299-308
22. Franchi C, Tettamanti M, Marengoni A, Bonometti F, Pasina L, Cortesi L, Fortino I, Bortolotti A, Merlino L, Lucca U, Riva E, Nobili A (2012) Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from Italian Medicines Agency. Results from the EPIFARM-Elderly Project. Eur Neuropsychopharmacol 22(8):569-577
23. WHO Collaborating Centre for Drug Statistics Methodology. The Anatomical Therapeutic Chemical (ATC) classification. About the ATC/DDD system. http://www.whocc.no/atcddd/. Accessed 15 June 2012
24. Istituto Nazionale di Statistica (ISTAT). http://www.istat.it/it/ archivio/44523. Accessed 15 July 2012
25. Getis A, Ord JK (1992) The analysis of spatial association by use of distance statistics. Geogr Anal 24:3
26. Anderson GF (2005) Medicare and chronic conditions. N Engl J Med 353:305-309
27. Milton JC, Hill-Smith I, Jackson SHD (2008) Prescribing for older people. BMJ 336:606-609
28. Omar RZ, O'Sullivan C, Petersen I, Islam A, Majeed A (2008) A model based on age, sex, and morbidity to explain variation in UK general practice prescribing: cohort study. Br Med J 337:238
29. Grimmsmann T, Himmel W (2009) Polypharmacy in primary care practices: an analysis using a large health insurance database. Pharmacoepidemiol Drug Saf 18:1206-1213
30. Bjerrum L, Søgaard J, Hallas J, Kragstrup J (1999) Polypharmacy in general practice: differences between practitioners. Br J Gen Pract 49(440):195-198
31. Progetto ARNO: Rapporto sul profilo prescrittivo della popolazione anziana. Rapporto 2001. CINECA. Centauro Editore, Bologna 2002